Drug & Digital Interventions

This feed describes how digital interventions, which are digital and mobile technologies used to support health system needs, can complement and improve pharmacotherapy in disease management. Discover the latest research on drug and digtial intervention here,

January 24, 2021

A Review of Venous Thromboembolism in COVID-19: In a Clinical Perspective.

The Clinical Respiratory Journal
Savas OzsuStavros V Konstantinides
January 23, 2021
Open Access

Associations between Pharmacotherapy for Cardiovascular Diseases and Periodontitis.

International Journal of Environmental Research and Public Health
Ewa Pająk-ŁysekJoanna Zarzecka
January 24, 2021

Technology-enhanced learning: a role for video animation.

British Dental Journal
Bernd StadlingerHendrik Terheyden
January 23, 2021
Open Access

Development and feasibility of a mobile phone application designed to support physically inactive employees to increase walking.

BMC Medical Informatics and Decision Making
Joanna Catherine NicholasCecilie Thøgersen-Ntoumani
January 23, 2021

Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health.

International Journal of Technology Assessment in Health Care
Sarah BerglasDaryl Bell
January 23, 2021
Open Access

Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.

The Lancet. Digital Health
Urs J MuehlematterKerstin N Vokinger
January 24, 2021

Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy is Associated with Decreased Fractures in Women with Breast Cancer.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Huifang LuMaria Suarez-Almazor
January 23, 2021
Open Access

Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer's Disease.

Hasan TurkezAdil Mardinoglu
January 23, 2021

Elimination of Aspirin From PCI Pharmacotherapy.

JACC. Cardiovascular Interventions
Sanjeev Kumar Agarwal, Shubham Agarwal
January 24, 2021

Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study.

Journal of the National Cancer Institute
Christopher J CadhamCISNET-SCALE Collaboration
January 24, 2021

Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study.

Clinical Drug Investigation
Matteo CasaleGiuseppe Dattilo
January 23, 2021

A qualitative study on the experiences of southern European immigrant parents navigating the Norwegian healthcare system.

International Journal for Equity in Health
Raquel Herrero-Arias, Esperanza Diaz
January 23, 2021

The safety of current pharmacotherapeutic strategies for osteosarcoma.

Expert Opinion on Drug Safety
Mariella Spalato, Antoine Italiano
January 24, 2021
Open Access

Advances in Brain Amyloid Imaging.

Seminars in Nuclear Medicine
Natasha KrishnadasChristopher C Rowe

Sign up to follow this feed and discover related papers.

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing studies have shed light on the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). This feed follows papers using RNA sequencing technologies in Alzheimer's research.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved